Related Experiment Videos
Diet, signal transduction and carcinogenesis
1Department of Medicinal Chemistry and Pharmacognosy, Purdue University, West Lafayette, IN 47907.
Abstract:
The defects in the regulation of cell growth and differentiation that manifest themselves as cancer result from multiple defective genes and their products, which are involved in the processes of cellular signaling, regulation of gene expression and control of the cell through its replication cycle. Each of these molecular defects represents a new target for development of novel therapeutic agents and prophylactic interventions. Evidence suggests that such therapeutic agents will show great efficacy for cells made cancerous by the single targeted defect. However, poor anticancer efficacy for clinically presenting cancer may occur as a result of the multiple molecular lesions. A combined-agent approach seems likely to be more successful, but this will require diagnosis of each tumor in substantially greater detail, down to the molecular level. When such molecular diagnosis becomes generally feasible, it should be possible to use combinations of highly specific agents at very low doses for therapy and ultimately for prevention of tumor metastasis. Chemoprevention in general may be achieved more easily than therapy with mechanism-based interventions, as certain individual lesions, in theory, may be rate limiting for carcinogenesis but may not be a significant contributor to the neoplastic phenotype by the time the tumor presents in the clinic.
Insights
Cancer arises from multiple gene defects. Targeted therapies may work for single defects, but combination treatments require detailed molecular tumor diagnosis for effective cancer therapy and prevention.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer develops due to dysregulation in cell growth and differentiation, stemming from multiple genetic defects.
- These defects impact crucial cellular processes including signaling, gene expression, and cell cycle control.
- Understanding these molecular underpinnings is key to developing effective cancer treatments.
Purpose of the Study:
- To explore the implications of multiple molecular defects in cancer development and treatment.
- To evaluate the potential of targeted therapeutic agents and prophylactic interventions.
- To discuss the necessity of molecular-level tumor diagnosis for combination therapies.
Main Methods:
- Review of existing evidence on cancer-related gene defects and therapeutic strategies.
- Analysis of the efficacy of single-agent versus combined-agent approaches in cancer treatment.
- Consideration of the role of molecular diagnosis in personalized cancer therapy and prevention.
Main Results:
- Single targeted defects show promise for specific cancer cells but may have limited efficacy in clinically presenting cancers due to multiple lesions.
- Combined-agent approaches are likely more successful but necessitate detailed molecular tumor profiling.
- Chemoprevention strategies targeting rate-limiting steps in carcinogenesis may be more achievable than therapy.
Conclusions:
- Effective cancer therapy and prevention, including metastasis control, will likely rely on combinations of highly specific agents.
- Achieving this requires advanced molecular diagnostics to tailor treatments to individual tumors.
- Mechanism-based chemoprevention may offer a more accessible route to cancer control than complex therapeutic interventions.